Methotrexate for maintenance of remission in igg4-related disease

Rheumatology (United Kingdom)

Volumn 54, Issue 10, 2015, Pages 1934-1936

  Della torre, Emanuel ^a,b   Campochiaro, Corrado ^a,b   Bozzolo, Enrica Paola ^b   Dagna, Lorenzo ^a,b   Scotti, Raffaella ^b   Nicoletti, Roberto ^c   Stone, John H ^d   Sabbadini, Maria Grazia ^a,b  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^b Unit of Medicine and Clinical immunology   (Italy)

^c SAN RAFFAELE HOSPITAL   (Italy)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G4; METHOTREXATE; PREDNISONE;

ABSENCE OF SIDE EFFECTS; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; DISEASE ACTIVITY; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG MEGADOSE; FOLLOW UP; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN G4 RELATED DISEASE; LETTER; MAINTENANCE THERAPY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REMISSION; RETROSPECTIVE STUDY; TREATMENT RESPONSE;

EID: 84943770425     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kev244     Document Type: Letter

References (8)

1. Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med 2012;366:539-51.
2. Khosroshahi A, Stone JH. Treatment approaches to IgG4-related systemic disease. Curr Opin Rheumatol 2011;23:67-71.
3. Ghazale A, Chari ST, Zhang L, et al. Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy. Gastroenterology 2008;134:706-15.
4. Carruthers MN, Stone JH, Deshpande V, et al. Development of an IgG4-RD Responder Index. Int J Rheumatol 2012;2012:259408.
5. Deshpande V, Zen Y, Chan JK, et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol 2012;25:1181-92.
6. Miranda-Carus ME, Balsa A, Benito-Miguel M, Perez de Ayala C, Martin-Mola E. IL-15 and the initiation of cell contact-dependent synovial fibroblast-T lymphocyte cross-talk in rheumatoid arthritis: effect of methotrexate. J Immunol 2004;173:1463-76.
7. Della-Torre E, Feeney E, Deshpande V, et al. B-cell depletion attenuates serological biomarkers of fibrosis and myofibroblast activation in IgG4-related disease. Ann Rheum Dis 2014 Aug 20. pii: annrheumdis-2014-205799. doi:10.1136/annrheumdis-2014-205799 [Epub ahead of print].
8. Wallace ZS, Mattoo H, Carruthers M, et al. Plasmablasts as a biomarker for igg4-related disease, independent of serum IgG4 concentrations. Ann Rheum Dis 2015;74:190-5.